Mawer Investment Management Ltd. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 13.8% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 112,030 shares of the healthcare conglomerate’s stock after selling 17,924 shares during the period. Mawer Investment Management Ltd.’s holdings in UnitedHealth Group were worth $41,124,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Nvwm LLC raised its stake in UnitedHealth Group by 89.2% during the 3rd quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 33 shares during the last quarter. Wellington Altus USA Inc. grew its stake in shares of UnitedHealth Group by 97.1% in the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock valued at $28,000 after purchasing an additional 33 shares during the last quarter. Security National Bank of SO Dak acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $29,000. Compass Wealth Management LLC purchased a new stake in shares of UnitedHealth Group during the third quarter worth approximately $29,000. Finally, Aberdeen Wealth Management LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $31,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Insiders Place Their Bets
In related news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.19% of the stock is owned by insiders.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on UNH shares. Erste Group Bank lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Mizuho upped their price objective on shares of UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a research report on Thursday, October 22nd. Zacks Research cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. Wall Street Zen raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Finally, Bank of America reiterated a “buy” rating and set a $450.00 price target on shares of UnitedHealth Group in a research note on Monday, July 20th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $463.93.
Read Our Latest Stock Report on UnitedHealth Group
UnitedHealth Group News Roundup
Here’s some of the latest news about UNH:
- Positive Sentiment: Recent commentary says analysts remain optimistic, and another article argues the shares may still be below fair value. It cites board changes and a sharper focus on medical-cost management and pricing as factors that could support earnings, though valuation depends on execution. Article: Do Wall Street Analysts Like UnitedHealth Group Stock? Article: UnitedHealth Group Stock Still Looks Below Fair Value After Board Appointment
- Neutral Sentiment: A technical analysis described UNH as consolidating, with neutral momentum and thin volume, suggesting no strong near-term signal from trading activity. Article: UnitedHealth Stock Price Prediction
- Negative Sentiment: Optum Rx’s prescription volumes declined, highlighting ongoing membership-related pressure even as segment earnings improved. Whether efficiencies and biosimilar adoption can sustain profit growth will matter to investors. Article: Can UNH’s Optum Rx Sustain Profit Growth as Prescription Volumes Fall?
UnitedHealth Group Price Performance
UNH stock traded up $2.49 during trading on Friday, reaching $407.62. 3,467,004 shares of the company were exchanged, compared to its average volume of 5,162,694. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The stock’s 50 day moving average price is $391.36 and its 200 day moving average price is $365.66. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The company has a market cap of $365.23 billion, a P/E ratio of 23.28, a PEG ratio of 1.47 and a beta of 0.51.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same period last year, the company posted $2.59 earnings per share. The firm’s quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts predict that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, December 7th will be issued a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is currently 53.00%.
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
See Also
- Five stocks we like better than UnitedHealth Group
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
